Osimertinib

N-[2-[[2-(Dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl]amino]phenyl]-2-propenamid

Stoffgruppe

Antineoplastisches Mittel (EGFR-Tyrosinkinase-Inhibitor)